The 3rd Cell Therapy Analytical Development Summit Europe returns to London to tackle regulatory bottlenecks head-on, make sure your company is represented. As the unmissable summit to connect with peers, share pain points and establish analytical standards for smoother interactions with regulatory bodies including the FDA, EMA and MHRA, make sure you are not left behind!

You will have the chance to connect with analytical development and quality control experts from industry leaders like Achilles Therapeutics, Avobis Bio, Bristol Myers Squibb, Johnson & Johnson, GSK, to tackle challenges from product characterisation to method validation and release preparation.

Seize the chance this September to collaborate, connect and share insights to drive the future development of potent, safe and effective autologous and allogeneic cell therapies forward.

Event Link here.